High-Level Gentamicin Resistance Mediated by a Tn 4001 -Like Transposon in Seven Nonclonal Hospital Isolates of Streptococcus pasteurianus
- 1 July 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (7) , 2508-2513
Abstract
We report on the first occurrence of high-level gentamicin resistance (MICs > or = 512 microg/ml) in seven clinical isolates of Streptococcus pasteurianus from Hong Kong. These seven isolates were confirmed to be the species S. pasteurianus on the basis of nucleotide sequencing of the superoxide dismutase (sodA) gene. Epidemiological data as well as the results of pulse-field gel electrophoresis analysis suggested that the seven S. pasteurianus isolates did not belong to the same clone. Molecular characterization showed that they carried a chromosomal, transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] which was known to encode a bifunctional aminoglycoside-modifying enzyme. The genetic arrangement of this transposon was similar to that of Tn4001, a transposon previously recovered from Staphylococcus aureus and other gram-positive isolates. Genetic linkage with other resistance elements, such as the ermB gene for erythromycin resistance, was not evident. On the basis of these findings, we suggest that routine screening for high-level gentamicin resistance should be recommended for all clinically significant blood culture isolates. This is to avoid the inadvertent use of short-course combination therapy with penicillin and gentamicin, which may lead to the failure of treatment for endocarditis, the selection of drug-resistant Streptococcus pasteurianus and other gram-positive organisms, as well as the unnecessary usage of gentamicin, a drug with potential toxicity.Keywords
This publication has 43 references indexed in Scilit:
- Genetic Basis of Antibiotic Resistance in Clinical Isolates ofStreptococcus gallolyticus(Streptococcus bovis)Antimicrobial Agents and Chemotherapy, 2005
- Streptococcus bovis Endocarditis and Its Association with Chronic Liver Disease: An Underestimated Risk FactorClinical Infectious Diseases, 2004
- High Prevalence of Inducible Erythromycin Resistance among Streptococcus bovis Isolates in TaiwanAntimicrobial Agents and Chemotherapy, 2001
- Aminoglycoside Resistance Genes aph(2")-Ib and aac(6′)-Im Detected Together in Strains of both Escherichia coli and Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 2001
- High-level resistance to gentamicin in Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 1992
- High-Level Gentamicin Resistance in Enterococcus: Microbiology, Genetic Basis, and EpidemiologyClinical Infectious Diseases, 1990
- High-Level Aminoglycoside Resistance Mediated by Aminoglycoside-Modifying Enzymes Among Viridans Streptococci: Implications for the Therapy for EndocarditisThe Journal of Infectious Diseases, 1987
- In Vitro and in Vivo Studies of Streptomycin-Resistant, Penicillin-Susceptible Streptococci from Patients with Infective EndocarditisThe Journal of Infectious Diseases, 1987
- Association ofStreptococcus boviswith Carcinoma of the ColonNew England Journal of Medicine, 1977
- Synergism with Aminoglycosides of Penicillin, Ampicillin and Vancomycin Against Non-Enterococcal Group-D Streptococci and Viridans StreptococciJournal of Medical Microbiology, 1977